(VOVWORLD) - Pfizer on Wednesday said it will set the US price for its COVID-19 antiviral treatment Paxlovid at nearly 1,400 USD per five-day course when it moves to...
(VOVWORLD) - The US Food and Drug Administration on Thursday granted full approval to Pfizer's oral antiviral COVID-19 treatment, Paxlovid, clearing the way for the drugmaker to sell the...
(VOVWORLD) - Pfizer said on Thursday it is seeking full U.S. approval for its oral COVID-19 antiviral treatment Paxlovid, which is currently available under an emergency use authorization (EUA)